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Major Director: Jeffrey L. Dupree, Ph.D. 
Associate Professor of Anatomy and Neurobiology 
 
 
Axonal domains are required for proper neuron function. These domains are unstable and 
degenerate concurrent with the inflammation in multiple sclerosis (MS) and the inflammatory 
disease models experimental autoimmune encephalomyelitis (EAE) and lipopolysaccharide 
(LPS) induced inflammation. Previous studies from our laboratory have shown that the axon 
initial segment (AIS) is maintained independently of the presence of myelin, but that AIS 
disruption is seen in MS as well as EAE and LPS-mediated inflammation. AIS loss can be 
interrupted in the early stage of EAE using the anti-inflammatory drug Didox. However, the 
potential for Didox directed repair of the AIS in later stages of disease has not been investigated. 
Here, we utilize two models of CNS inflammation to assess the possibility of reversing AIS 
pathology. Based on our findings, we present the first evidence that AIS degeneration, an axonal 
pathology observed in MS and in chronic inflammation, is reversible.
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CHAPTER 1: Introduction 
 
 
The human brain is a highly complex and segmented collection of around 86 billion cells 
that function in specialized units to process information and respond to the environment 
(Azevedo et al., 2009). The complexity and segmented nature of the brain is reflected in the 
basic cellular unit of the brain: the neuron. Neurons are highly specialized polar cells that can be 
divided into two primary domains known as the somatodendritic domain and the axonal domain. 
The proper function of the neuron (and the nervous system as a whole) depends on the formation 
and maintenance of these domains. Our research focuses on a subdomain of the axon called the 
Axon Initial Segment (AIS). While structurally very similar to another axonal domain called the 
node of Ranvier, the initial segment is both formed and maintained in a myelin-independent way 
(Clark et al., 2016; Hamada and Kole, 2015; Normand and Rasband, 2015). Loss or dysfunction 
of the AIS has been described in models of stroke (Schafer et al., 2009), schizophrenia (Volk and 
Lewis, 2005), traumatic brain injury (Baalman et al., 2015) and now in models of multiple 
sclerosis (Clark et al., 2016). Understanding the processes and mechanisms that regulate the AIS 
can yield important insights into therapeutic drugs or treatments for diseases that affect it. In this 
introduction I will explore the broad function of neuronal domains, and then focus on the 
structure and function of the AIS. I will discuss the major molecular components, the formation, 
and what is currently known about regulation and maintenance before describing previous results 
and the hypothesis driving this work.  
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Neuronal Domains: Somatodendritic Domain 
 
The neuron can be broadly divided into the somatodendritic and axonal domains (Britt et 
al., 2016) (Figure 1). The somatodendritic domain is the location of the nucleus and is primarily 
responsible for receiving and integrating synaptic input for propagation in the axonal domain. It 
contains high concentrations of neurotransmitter receptors, synaptic density proteins like post-
synaptic density-95 (PSD-95), and cell adhesion molecules important for synaptic transmission 
(FarÃas et al., 2012; Horton and Ehlers, 2004).  
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Figure 1. The neuron and neuronal domains. The neuron can be broadly divided into 
the somatodendritic domain (composed of the dendrites and soma), and the axon (A). The 
axon itself is divided into sub domains such as the axon initial segment and nodes of 
Ranvier. The axon initial segment is the portion of the axon immediately distal to the 
soma and is responsible for initiating action potentials. In myelinated axons, nodes of 
Ranvier are located between successive myelinated segments of axon. The initial segment 
and node cluster many similar proteins (B). 
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Neuronal Domains: Axonal Domain 	
The axon itself can be subdivided into a number of subdomains based on molecular 
composition and function. Two vital domains of the axon are the axon initial segment (AIS) and 
the node of Ranvier. The AIS is located immediately distal to the soma is responsible for 
initiating action potentials, while the node of Ranvier exists between segments of myelin and 
propagates these potentials down the axon. Reflected in their similar roles is a similar molecular 
composition. The node of Ranvier and AIS cluster many similar molecules, although they are 
formed and maintained in distinct ways.  
Axonal Domain: The node of Ranvier  	
The node of Ranvier is an electrically active domain of the neuron and myelin is essential 
for nodal protein clustering. Voltage gated sodium channels (Nav) are nodal proteins that provide 
the primary driving force of this electrical activity by allowing sodium ions to pass through the 
membrane. Early experimenters exploited an in vitro remyelinating model and demonstrated that 
the process of myelination regulated sodium channel clustering (Vabnick et al., 1996). These 
results were confirmed in vivo through the use of a demyelinating-remyelinating model, which 
further demonstrated that sodium channel clustering was dependent on the presence of a myelin 
sheath (Dupree et al., 2004). More recent work has shown that the myelin protein neurofascin-
155 binds the axonal complex of caspr and contactin, resulting in a stable myelin-axon bond and 
the formation of mechanical barriers that limit lateral movement of the Nav channels (Susuki and 
Rasband, 2008). In addition to the myelin sheath, the extracellular matrix and the axonal 
cytoskeleton also play critical roles in maintaining the node of Ranvier. Neurofascin-186, the 
neuronal isoform of the neurofascin gene, binds either extracellular matrix proteins or glial 
proteins, resulting in the stabilization of the node. For example, in the peripheral nervous system, 
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neurofascin-186 binds the Schwann cell protein gliomedin to stabilize nodal structure (Amor et 
al., 2014). In addition, neurofascin-186 also assists in assembling and maintaining the node by 
binding the cytoskeletal scaffolding protein Ankyrin-G. Ankyrin-G in turn anchors Nav channels 
in the axonal membrane. Taken together, multiple intrinsic and extrinsic mechanisms work in 
concert to ensure the structure and function of the node of Ranvier, which is essential for nervous 
system function.  
Axonal Domain: The Axon Initial Segment 	
As the initiator of action potentials, the AIS contains a complex membrane and 
cytoplasmic architecture that allows it to generate ionic currents to encode information. As an 
electrically active domain, the key components of the initial segment includes sodium and 
potassium channels, and the cellular adhesion molecule Neurofascin-186 on the membrane, as 
well as the scaffolding protein Ankyrin-G and the cytoskeletal protein βIV spectrin.  
Proteins of the Axon Initial Segment  
Ankyrin G 	
Ankyrins are a class of adaptor proteins that link membrane bound ion channels to the 
spectrin-actin cytoskeleton (Bennett and Baines, 2001; Zhang and Bennett, 1998). There are 
three main Ankyrin proteins in mammals: Ankyrin-R, Ankyrin-B, and Ankyrin-G. Ankyrin-R is 
the product of the ANK1 gene and is primarily found in erythrocytes; Ankyrin-B is broadly 
expressed and is the product of the gene ANK2; Ankyrin-G is the product of ANK3 and is 
considered vital to neuronal structure and function (Bennett and Baines, 2001; Kizhatil et al., 
2007). Different subtypes of these Ankyrins are produced through alternative splicing, further 
increasing the diversity of this protein family (Bennett and Baines, 2001).  
	 6	
Generic Ankyrins are composed of a membrane binding domain on the NH2-terminus 
containing 24 copies of the 33 residue ANK repeat, a variable-length spectrin binding domain, 
and a death domain at the C-terminal end (Bennett and Baines, 2001; Kizhatil et al., 2007). 
Through death domains are known to activate caspase proteases and cell death in other cells, it 
currently has no known role in Ankyrins (Bennett and Baines, 2001; Mohler et al., 2002). 
Ankyrin-B and Ankyrin-G are similar in structure and are both found in neurons, although 
Ankyrin-B is widely dispersed throughout axons and cell bodies while Ankyrin-G is primarily 
localized at the axon initial segment and nodes of Ranvier (Bennett and Baines, 2001; Kordeli et 
al., 1995; Zhang and Bennett, 1998). Ankyrin-G is primarily located in the AIS and nodes of 
Ranvier in the form of a 480 or 270-kD alternatively spliced isoform. These isoforms differ only 
in the length of a 2300 amino acid unstructured tail (Leterrier, 2016). The localization of 
Ankyrin-G at the AIS but not Ankyrin-B is thought to come from targeting information in the 
spectrin binding domain as well as the serine-rich tail domain, which are unique to Ankyrin-G. 
Evidence suggests that Ankyrin-G accumulates at the initial segment due to exclusion from the 
distal axon mediated by Ankyrin-B and αII/βII spectrin, as opposed to direct recruitment by an 
unidentified receptor(Galiano et al., 2012; Normand and Rasband, 2015).  
βIV Spectrin 	
The primary known role of Ankyrin-G at the initial segment is to bind and localize 
sodium channels. In order for the Ankyrin-sodium channel structure to be stable and functional, 
it must also be linked to the actin cytoskeleton. βIV spectrin, a cytoskeletal protein arranged as a 
hetero-tetramer, serves this role at the initial segment and nodes of Ranvier (Bennett and Baines, 
2001; Rasband, 2010). Like Ankyrins, spectrins are a diverse class of molecules. They are 
composed of α and β subunits, and these subunits undergo differential splicing, further 
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increasing the diversity.  β spectrins have 19 domains: an NH2-terminal actin binding domain, 17 
triple helical repeat domains (spectrin repeats), and a COOH end with a pleckstrin homology 
domain (Bennett and Baines, 2001). At the initial segment and nodes of Ranvier, Ankyrin-G 
binds with βIV spectrin at spectrin repeat 15, which is also necessary for βIV spectrin 
localization at the AIS (Yang et al., 2007). The binding between Ankyrin-G and βIV spectrin has 
been shown to be specific to Ankyrin-G, as Ankyrin-B and Ankyrin-R do not co-localize with 
βIV spectrin as well as Ankyrin-G in immunoprecipitation assays (Yang et al., 2007). βIV 
spectrin has six alternatively spliced isoforms, but two are localized at initial segments and nodes 
of Ranvier: βIV spectrin 𝚺1 and βIV spectrin 𝚺6 (Komada and Soriano, 2002; Lacas-Gervais et 
al., 2004; Yang et al., 2004; Yang et al., 2007). 
Neurofascin-186 	
Along with the cytoskeletal components of the initial segment, Neurofascin-186 of the L1 
family of cellular adhesion molecules (L1 CAM) is also present. Neurofascins in particular are 
important for AIS development, and as previously discussed they are also involved in node of 
Ranvier development through mediating glial-neuron contact and protein clustering (Davis et al., 
1993; Hassel et al., 1997; Sherman et al., 2005). Neurofascin-186 is known to bind Ankyrin-G 
(Davis et al., 1993) and the importance of Neurofascin-186 at the initial segment is highlighted 
in conditional knockout mice, which rapidly lose sodium channel labeling within 4 weeks (Zonta 
et al., 2011).  
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Sodium Channels  	
Neurons are electrically active cells that actively maintain a chemical-electrical voltage 
gradient over its membrane equal to about -70 to -80mV relative to the extracellular 
environment. Sodium ions are the dominant carrier of charge in vertebrate nervous systems 
(Castelfranco and Hartline, 2016). For electrically active domains like the AIS and node of 
Ranvier, voltage gated sodium channels are essential.  
Voltage gated sodium channels respond to depolarizing signals that cause the channels to 
open. When the channels open, sodium ions flow across the membrane and into the neuron due 
to the chemical (concentration) electrical (-70mV) gradient. This flux of sodium ions causes a 
temporary flip in membrane potential, which can be propagated along the axon (by opening 
neighboring sodium channels). This flip in membrane potentials is propagated along an axon and 
is called the action potential (Castelfranco and Hartline, 2016). The propagation of action 
potentials is greatly increased in speed by the advent of myelin, the fatty insulation covering a 
large portion of axons in the vertebrate central and peripheral nervous system. The axon initial 
segment and node of Ranvier are two unmyelinated segments of the axon, which are involved in 
the generation and propagation of action potentials (respectively). Not surprisingly, both of these 
domains contain a density of sodium channels. Although sodium channels are transmembrane 
proteins, they still require other molecules to anchor them in place in order to properly function. 
Ankyrins are known to interact with sodium channels through their membrane binding head 
domain. Sodium channels that are not linked to Ankyrin-G are quickly removed from the 
membrane via endocytosis (Fache et al., 2004). Specialized sodium channels such as Nav1.6 are 
present at the initial segment and nodes along with Ankyrin-G (Bennett and Baines, 2001; 
Jenkins and Bennett, 2001; Pan et al., 2006; Zhang and Bennett, 1998). Nav1.6 are not the only 
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ion channels at the initial segment and node. Nav1.2, potassium channels, and calcium channels 
are also present and known to interact with Ankyrin-G at these domains.  
Formation of the Axon Initial Segment 
 
The localization of Ankyrin-G at the initial segment and node of Ranvier indicates a vital 
role at these specialized cellular domains. Early work with the alternatively spliced 480/270 kD 
Ankyrin-G indicated that it co-localized with sodium channels (Deerinck et al., 1997), 
Neurofascin, and βIV spectrin (Jenkins and Bennett, 2001; Zhang and Bennett, 1998). Further 
work by Rasband et al. and others also indicated that Ankyrin-G and βIV spectrin were present 
at nodes and initial segments and necessary for ion channel localization (Jenkins and Bennett, 
2001; Rasband et al., 1999; Zhang and Bennett, 1998). The localization and binding partners 
emphasize the importance of Ankyrin-G and βIV spectrin to the initial segment. But which 
protein(s) are responsible for the development of the initial segment?  
Work done first by Zhou et al. (1998) and then by Jenkins et al. (2001) with cerebellar 
specific knockouts of Ankyrin-G supported the idea that Ankyrin-G was the primary initial 
segment organizer. Zhou et al. (1998) used a cerebellar specific Ankyrin-G knockout mouse and 
showed that the clustering of both sodium channels and Neurofascin was impaired at the axon 
initial segment (Zhou et al., 1998). The knockout mice in this study demonstrated clear deficits 
in action potential initiation and firing. Jenkins and Bennett (2001) also sought to evaluate the 
possible candidates (L1 CAMs, βIV spectrin, Ankyrin-G) for initial segment organization using 
the Ankyrin-G knockout mice. They demonstrated that mice lacking Ankyrin-G did not cluster 
βIV spectrin, Nav, or L1 CAMs, and did not form functional initial segments in cerebellar 
Purkinje neurons lacking Ankyrin-G. The symptoms of cerebellar Ankyrin-G knockout mice 
include tremor, impaired Purkinje neuron firing, and neuronal degeneration. The authors attribute 
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these symptoms to a loss of sodium channels at the initial segments, likely caused by the lack of 
Ankyrin-G (Jenkins and Bennett, 2001) 
Although the findings of Zhou et al. (1998) and Jenkins and Bennett (2001) demonstrate 
that Ankyrin-G is an important organizer of the initial segment, Komada and Soriano (2002) 
developed a mouse carrying a null mutation in the βIV spectrin gene and showed that both 
Ankyrin-G and sodium channel staining was affected by the loss of βIV spectrin. Using a pan-
sodium channel antibody and an anti-Ankyrin-G antibody, they observed only faint labeling for 
sodium channels and Ankyrin-G when βIV spectrin was absent, which is shown in stark contrast 
to the uniform localized staining for these proteins at the initial segment of wild type mice 
(Komada and Soriano, 2002) Symptoms of βIV spectrin mutant mice included tremors and 
contraction of hind limbs, and these symptoms grew more severe with age. It is interesting to 
note that while the symptoms of βIV spectrin null animals and cerebellar Ankyrin-G knock out 
mice both affected movement, the symptoms of the βIV spectrin null mice were less severe than 
those of the cerebellar specific Ankyrin-G knock out mice (Komada and Soriano, 2002) This 
could be due to the fact that there were still low levels of Ankyrin-G and Nav labeling in βIV 
spectrin mutant mice, whereas this labeling was absent in Ankyrin-G knockout animals.  
Yang et al. (2004) showed a similar pattern existed at nodes of Ranvier using the quiver 
(qv3j) mice, which produced a truncated form of βIV spectrin lacking the pleckstrin homology 
domain. These mice displayed CNS nodes that were 2X longer than normal nodes and they had 
striking membrane protrusions when examined under electron microscope (Yang et al., 2004). 
Later in-vitro studies by Yang et al. (2007) provided evidence that βIV spectrin binds to 
Ankyrin-G through spectrin repeat 15, and that this repeat is essential to βIV spectrin 
localization at the initial segment. It was still unclear whether βIV spectrin localized Ankyrin-G 
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to the AIS or if Ankyrin-G localized βIV spectrin. In order to address this question, Yang et al. 
(2007) co-transfected cultured hippocampal neurons with green fluorescent protein-labeled 
Ankyrin-G that was missing the NH2-terminal membrane-binding domain and Myc-labeled βIV 
spectrin. This experiment demonstrated that when Ankyrin-G does not have its membrane 
binding domain, βIV spectrin and Ankyrin-G still bound to one another, but they did not localize 
at the initial segment. Instead, these protein complexes were spread throughout the cell. The 
modified Ankyrin-G even had the effect of disrupting the localization of endogenous βIV 
spectrin. These experiments were initially done with cultured embryonic hippocampal neurons in 
vitro, but were also replicated in-vivo (Yang et al., 2007). 
Taken together, these studies demonstrated the importance of βIV spectrin and Ankyrin-
G in the formation and stability of the protein complexes at the initial segment and node of 
Ranvier, while also singling out Ankyrin-G as the initial organizer. These studies demonstrate 
why Ankyrin-G has come to be known as the master organizer of the AIS (Jenkins and Bennett, 
2001; Normand and Rasband, 2015; Sobotzik et al., 2009; Szu-Yu Ho and Rasband, 2011) 
Functions and Maintenance 
Maintaining Polarity 
 
As previously discussed, neurons are segmented, polarized cells. As well as being the 
initiator of action potentials, the initial segment also serves as an important barrier between the 
somatodendritic domain and the axonal domains of the neuron.  
Work by Nakada et al. (2003) sought to investigate the presence of a hypothesized 
membrane diffusion barrier in cultured hippocampal neurons using a fluorescently labeled 
phospholipid and looking for movement restrictions across the initial segment. If there was 
restriction of movement at the initial segment, it would be evident by watching this molecule 
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move across it. Nakada et al. (2003) was able to show that movement was reduced by a factor of 
about 800 at Ankyrin-G positive axon initial segments, indicating the presence of a barrier to 
lipid diffusion. This barrier to lipid diffusion only emerged at the initial segment gradually 
between 1 and 10 days in vitro, with the most dramatic losses in mobility between days 7-10. 
The diffusion barrier at the membrane was at least partially due to the presence of actin, as 
depolymerization of fibrous-actin led to increased mobility of lipids at the initial segment. The 
restriction was then attributed to steric hindrance at the surface due to the accumulation of 
Ankyrin-G and Nav complexes at the initial segment, which are anchored to the actin 
cytoskeleton (Nakada et al., 2003).  
Work by Song et al. demonstrated the presence of a cytoplasmic barrier at the initial 
segment that served as a passive barrier depends on both Ankyrin-G and fibrous-actin by 
tracking the diffusion of different sized dextrans along the axon (Song et al., 2009). As in 
previous initial segment barrier experiments (Nakada et al., 2003), Song et al. (2009) noticed the 
effects of this barrier develop over the course of 3-7 days in vitro; observing almost free 
diffusion at 3 days in vitro, and markedly reduced movement by 5 days in vitro (Song et al., 
2009).  
Proteins and Polarity 	
Once this barrier is set up, it acts as a fence to separate the somatodendritic and axonal 
domains and keep specialized domain functions occurring in their respective compartments 
(Rasband, 2010). The proper function of the domains and the neuron as a whole now depends on 
the presence of this barrier. In a series of experiments performed to investigate the protein 
components responsible for the maintenance of this fence, Hedstrom et al. (2008) used RNA 
interference to silence the expression of initial segment proteins in cultured hippocampal 
	 13	
neurons. Silencing experiments were performed on Neurofascin-186, Ankyrin-G, Nav, and βIV 
Spectrin. Results indicated that Neurofascin-186, Nav, and βIV spectrin all had long half-lives 
and silencing did not greatly affect immunolabeling of these proteins for up to 2 weeks after 
transfection. However, Ankyrin-G silencing led to a significant loss of Ankyrin-G 
immunolabeling within 7 days post transfection, and this depletion also led to a dramatic loss of 
other initial segment proteins (Hedstrom et al., 2008). In order to examine the effects of silencing 
on neuronal polarity, microtubule associated protein-2 (MAP2), a protein normally restricted to 
the somatodendritic domain, was immunolabeled 10 days after Ankyrin-G silencing. In 
untransfected neurons, MAP2 was restricted to the somatodendritic domain with fluorescent 
intensity decreasing across the initial segment. However, at 10 days post infection, almost all 
neurons had MAP2 in all visible processes, and processes that were identified as axons based on 
morphology were found to be positive for the excitatory synapse protein PSD-95, indicating the 
presence of dendritic spines (Hedstrom et al., 2008). These findings indicated that neuronal 
polarity had been lost along with the Ankyrin-G. 
Using Ankyrin-G knockout mice that also expressed GFP in their Purkinje cells, Sobotzik 
et al. (2009) investigated axon polarity in the absence of Ankyrin-G in vivo. Purkinje cells were 
used in these experiments because they have a unique morphology that allows the clear 
identification of the axon as the long process on the opposite pole of the dendritic tree (Rasband, 
2010; Sobotzik et al., 2009). In these mice, the axon formed normally, but close examination of 
axons in Ankyrin-G knock outs revealed the presence of a number of short protrusions which 
resemble dendritic spines (Sobotzik et al., 2009). Further examination of these axonal spines 
indicated that they also contained postsynaptic density proteins common in dendritic spines. 45% 
of axons in the cerebellar nodule had the unusual spiny phenotype, which was not seen in control 
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animals (Sobotzik et al., 2009) These results provide evidence that the lack of Ankyrin-G 
prevents barrier formation between the somatodendritic and axonal domains, causing a dendritic 
phenotype to develop in the axonal domain in vivo as well as in vitro.    
Ankyrin-G is both the master organizer of the initial segment and it also has roles in the 
maintenance of axonal specificity, making it a particularly vital protein for proper neuron 
function. Other proteins at the initial segment like Neurofascin-186 and Nav are important for 
initial segment function, but have not been shown to be as vital to the integrity of the barrier and 
functional compartment as Ankyrin-G.  
βIV spectrin, while it is not the initial organizer of the AIS, has been shown to be 
essential to the maintenance and stability of this domain (Komada and Soriano, 2002; Yang et 
al., 2004; Yang et al., 2007) As previously described, there are two major isoforms of βIV 
spectrin at the initial segment and nodes of Ranvier, but βIV spectrin 𝚺1 has been shown to be 
the vital isoform (Lacas-Gervais et al., 2004). When βIV spectrin 𝚺1 is knocked out, mice 
display nodes that are longer than normal (81% were >1.5μm, while only 11% of control mice 
had nodes >1.5 μm) and also had abnormal initial segment structure (Lacas-Gervais et al., 2004). 
Nerve conduction was also negatively affected in these animals, which may explain the 
quivering phenotype (Lacas-Gervais et al., 2004).  βIV spectrin mutants have also been shown to 
mislocalize Nav channels at initial segments and nodes of Ranvier, which likely accounts for the 
quivering symptoms in knockout mice.  
Taken together, these studies indicate that βIV Spectrin is important for the long-term 
stability of the initial segment as opposed to the initial setup. So while Ankyrin-G may be the 
master organizer, βIV spectrin is also an essential protein required for proper function and 
stability of the initial segment. 
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Pathology of the AIS 
Multiple Sclerosis 	
Multiple Sclerosis (MS) is an inflammatory demyelinating disease that affects an 
estimated 2.3 million people worldwide and is most often diagnosed in adults between the ages 
of 20-50. It is a wide-ranging disease in terms of symptoms; with vision, balance, gait, and 
cognition often affected (Anonymous; Minden and Schiffer, 1990). Despite the severity and wide 
ranging symptoms, the etiology of MS is still largely unknown. The disease is considered 
immune-mediated and presents with focal demyelination and inflammation of the 
CNS(Constantinescu et al., 2011; Leray et al., 2010) The devastating effects of MS are 
colloquially attributed to these demyelinating lesions, but as well as being a demyelinating 
disease, there is also a significant inflammatory aspect to MS (Constantinescu et al., 2011). In 
fact, the degree of inflammation closely correlates with disability and is present from the onset of 
disease and even before demyelination (Bjartmar et al., 2001; Kornek et al., 2000). Bjartmar et 
al. (2001) has demonstrated that axonal injury occurs in normal appearing white matter before 
lesions appear in early MS. MS is a disease characterized by both inflammation and 
demyelination, and they have important consequences for the maintenance of the major 
functional domains of the axon (Larochelle et al., 2016; Leray et al., 2010).  
Although structurally and functionally very similar, the AIS and the node of Ranvier are 
formed in distinct ways-- with the initial segment being formed intrinsically by the neuron and 
the nodes of Ranvier depending on glial contact and secreted factors. Another interesting 
discrepancy in these domains is their responses to disease. In demyelinating models of MS in 
which an oligodendrocyte toxin is fed to mice and dramatic demyelination is observed, the 
cluster of proteins that defines a node of Ranvier disperses and can no longer be detected with 
immunocytochemistry. Upon remyelination, the nodal proteins re-cluster (Dupree et al., 2004). It 
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has recently been shown that the initial segment does not degenerate following the loss of myelin 
(Clark et al., 2016; Hamada and Kole, 2015). This discrepancy is interesting in and of itself-- 
why do these virtually identical domains form in different ways and respond differently to 
disease? Preliminary evidence from our lab also indicates that the initial segment does 
degenerate in human multiple sclerosis (Figure	2) (Thummala, 2015).  
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Figure 2. AIS degeneration in MS. Antibodies directed against Ankyrin-G (red, white arrows) 
robustly label AISs in non-MS brain tissue (A). Although AISs were observed in comparable 
brain regions from MS brains (B), the number of AISs was reduced in the MS tissue by about 
30% (C). Average length of AISs in the non-MS and MS samples were not different (D). Nuclear 
staining with Bis-benzamide (blue) suggests no loss in cell number. Human tissue was obtained 
from the Rocky Mountain MS Center tissue bank. Data and figure from Thummala, 2015.  
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Since inflammation is another other major pathology in MS, we hypothesized that 
inflammatory-dependent axonal pathology causes the breakdown of the initial segment in MS. 
This is supported by previous work indicating a dual pathology in MS with demyelination and 
inflammation (Leray et al., 2010). The demyelination could lead to a loss of nodal clustering, 
while inflammation could lead to a loss of initial segments. To examine the effects of 
inflammation at the AIS, we used the inflammatory model of MS called Experimental 
Autoimmune Encephalomyelitis (EAE) as well as the inflammatory molecule 
Lipopolysaccharide (LPS) to induce inflammation.  
Experimental autoimmune encephalomyelitis 
 
EAE is a common animal model for MS.  Like MS, it is a T-cell mediated disease 
characterized by inflammation and demyelination of the CNS (Gold et al., 2006; Kipp et al., 
2009; Kipp et al., 2012). In EAE, a myelin antigen is injected along with Freund’s complete 
adjuvant (mineral oil + heat killed m. Tuberculosis), and pertussis toxin, though specific 
protocols differ (Clark et al., 2016; Dupree et al., 2015; Gold et al., 2006). This cocktail 
stimulates an inflammatory immune response by macrophages, microglia, and T-cells against the 
CNS (Gold et al., 2006; Nicholson et al., 2009). EAE is unlike MS in that the specific antigens 
that can be used to induce it are known (Constantinescu et al., 2011; Huang et al., 2014; Huber et 
al., 2013). Proteolipid protein, myelin basic protein, and myelin oligodendrocyte glycoprotein 
(MOG) are common CNS antigens used to induce EAE (Kipp et al., 2012; Ramanathan et al., 
2016; Recks et al., 2015; Terry et al., 2016). However, the presence of a CNS antigen is not 
directly required to induce EAE. Since it is a T-cell mediated disease, EAE can be stimulated in 
a healthy animal through transfer of T-cells from an EAE animal in a process known as 
“adoptive transfer” (Kipp et al., 2012; Zamvil et al., 1985). Regardless of the antigen or 
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technique used, the purpose is to stimulate an immune response against the CNS that resembles 
MS. The other components of the mixture used to induce EAE serve to stimulates toll-like 
receptors (TLR) on T-cells, priming them for an inflammatory immune response (Freund’s 
complete adjuvant), and also disrupting the blood brain barrier and further inflaming the immune 
system (pertussis toxin) (Kipp et al., 2012; Richard et al., 2011). 
For the current study, a segment of the MOG protein (amino acids 35-55) found on the 
N-terminal extracellular domain was used as the CNS antigen due to its effectiveness in 
stimulating a chronic encephalitic response in the CNS of C57/Bl6 mice (Ramanathan et al., 
2016; Terry et al., 2016). MOG exists in the CNS on the outer myelin layer and on the surface of 
mature oligodendrocytes, making it an accessible antigen (Gold et al., 2006; Ramanathan et al., 
2016). Antibodies to MOG have been shown to modify CNS inflammation, and T-cells can cross 
the blood brain barrier, further exacerbating the disease (Ramanathan et al., 2016). The 
inflammation in EAE (and MS) is associated with elevated levels of the inflammatory molecules 
tumor necrosis factor alpha (TNFα) and inducible nitric oxide synthase (iNOS) (Ummenthum et 
al., 2016; Valentin-Torres et al., 2016) 
Lipopolysaccharide induced inflammation 
 
As discussed previously, inflammation is a major insult in MS (Leray et al., 2010) and 
the inflammatory model EAE (Gold et al., 2006; Kipp et al., 2012; Varatharaj and Galea, 2016). 
Another molecule known to instigate an inflammatory response is lipopolysaccharide (LPS). 
LPS is an endotoxin found on the membrane of gram-negative bacteria that, like Freund’s 
complete adjuvant in EAE, stimulates toll like receptors (TLRs) to induce an inflammatory 
response (Christmas, 2010; Heneka et al., 2000; Hoshino et al., 1999; Li et al., 2016; Qin et al., 
2007). Similarly to EAE, peripheral LPS administration leads to the production of inflammatory 
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compounds such as TNFα and iNOS, and leads to neuronal damage as well as causing microglia, 
the immune cells of the CNS, to adopt a reactive morphology known as M1 activation 
(Fukushima et al., 2015; Hoshino et al., 1999; Liu and Bing, 2011; Qin et al., 2007; Taetzsch et 
al., 2015; Varatharaj and Galea, 2016). LPS induced inflammation is similar to the inflammatory 
aspects of EAE, while also being independent of peripheral immune cell infiltration. After a 
single peripheral administration of LPS (5mg/kg), we do not observe T-cell infiltration (Benusa 
and Dupree, unpublished observations). This makes LPS induced inflammation a valuable model 
to further investigate the effects of inflammation at the AIS. 
Microglia: Immune Cells of the CNS 
 
Microglia are considered the macrophages and resident immune cells of the CNS 
(Hanisch and Kettenmann, 2007). In the CNS, microglia exist along a spectrum of activation 
states. In the surveying state, microglia maintain a stationary cell body and are actively surveying 
the surrounding brain environment with processes extending to sample the environment at an 
average rate of ~1.5µm/minute (Blaylock, 2013; Hanisch and Kettenmann, 2007; Nimmerjahn et 
al., 2005). Upon detection of a pathogen, signal or distress, microglia shift their level of 
activation by adopting an ameboid form and initiating transcriptional changes that make them 
actively phagocytic and pro-inflammatory. Activation of microglia broadly cooresponds to 
macrophage activation, and can be termed M1 activated (classical activation, proinflammatory), 
or M2 activated (alternative activation, a complex state, but sometimes associated with healing) 
(Blaylock, 2013; Boche et al., 2013; Kettenmann et al., 2013; Taetzsch et al., 2015). M1 
activated microglia secrete the pro-inflammatory molecule TNFα, as well as increasing 
production of iNOS. iNOS is an enzyme that creates nitric oxide, a nitrogen radical and cell 
signaling molecule that can combine with oxygen radicals to create a destructive peroxynitrite 
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radical, further contributing to an inflammatory environment associated with neuronal damage 
(Blaylock, 2013; Ghasemi and Fatemi, 2014; Valentin-Torres et al., 2016). Microglia can both 
respond to and create inflammation, and while these cells are vital to the health and proper 
function of the brain, persistent M1 activation is associated with CNS damage in 
neurodegenerative diseases (Blaylock, 2013; Ghasemi and Fatemi, 2014; Hanisch and 
Kettenmann, 2007; Taetzsch et al., 2015; Valentin-Torres et al., 2016). Microglia were 
investigated in this study as possible mediators or AIS pathology. 
Didox  
 
Based on the hypothesis that inflammation is a major cause for damage to the initial 
segment, we treated animals with an anti-inflammatory drug called 3,4-
dihydroxybenzohydroxamic acid, Didox (Molecules for Health Inc., Richmond, VA). Didox is a 
multifunctional drug that is a potent ribonucleotide reductase inhibitor and anti-inflammatory 
(Inayat et al., 2010; Matsebatlela et al., 2015; Shah et al., 2015). The enzyme ribonucleotide 
reductase controls the rate limiting step in DNA synthesis, and inhibiting this enzyme is likely to 
affect rapidly dividing cells, such as those in tumors (Shah et al., 2015). Didox has been used for 
treating cancer (Shah et al., 2015) and it is also effective against inappropriate immune 
responses, such as those seen in graft versus host disease (Inayat et al., 2010). In a study 
examining allogeneic (antigenically foreign transplant tissue) inflammatory responses, Inayat et 
al. (2010) investigated the effects of Didox treatment on T-cells stimulated with anti-CD3-𝞊 
antibodies. Treatment with this antibody normally causes T-cells to proliferate and produce 
inflammatory cytokines, but they found that Didox blocked proliferation in the presence of anti-
CD3-𝞊 without significant cell death. It also blocked the production of interferon-𝛄 (IFN-
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𝛄), interleukin (Il)-4, and Il-6; which are all factors normally produced by inflamed T-cells 
(Inayat et al., 2010).  
Macrophages have also been shown to be involved in inflammation through production 
of inflammatory cytokines and chemokines, reactive oxygen species, and phagocytosis 
(Matsebatlela et al., 2015; Wu et al., 2016). In order to determine the effectiveness of Didox in 
suppressing macrophage-mediated inflammation, Matsebatlela et al. (2015) used quantitative 
reverse transcriptase polymerase chain reaction (qRT-PCR) and other assays to examine the 
expression of murine macrophages under three conditions: LPS treatment, Didox treatment, and 
LPS + Didox. Didox significantly reduced the expression of inflammatory cytokines (TNFα, Il-
6, Il-10) and inflammation-associated enzymes (iNOS, COX-2) normally produced in response 
to LPS (Matsebatlela et al., 2015). Didox also prevented the translocation of nuclear factor kappa 
B (NFκB) to the nucleus, which could account for the suppressed inflammatory response in 
Didox treated macrophages (Matsebatlela et al., 2015). Due to the anti-inflammatory properties 
and results from previous studies, Didox was used for treatment of EAE and LPS-induced 
inflammation in this study.  
Hypothesis 
 
Our laboratory has previously shown that initial segments shorten in Early EAE, and 
significantly decline in number at the Late EAE time point(Clark et al., 2016) We proposed that 
attenuation of CNS inflammation might dampen the inflammatory-induced pathology. To test 
this hypothesis, mice were treated at Early EAE with the anti-inflammatory drug Didox. When 
treated at the early phase with Didox, the initial segments do not decrease in number at the Late 
EAE time point. This was a striking finding, as other studies indicated that the loss of initial 
segments was a permanent event (Schafer et al., 2009; Szu-Yu Ho and Rasband, 2011). If anti-
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inflammatory treatment was ameliorating the degeneration of initial segments, could it also lead 
to the recovery of lost initial segments? This question led to my hypothesis: resolution of 
inflammation will rescue AIS disruption. We set about addressing this question using Didox to 
reduce inflammation in the previously described inflammatory disease models, EAE and LPS-
mediated inflammation. 
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CHAPTER 2: Materials and Methods 
 
Animals 	
Female C57BL/6 mice were obtained at 11 weeks of age from Jackson Laboratories (Bar 
Harbor, ME) and maintained in the Hunter Holmes McGuire Veterans Affairs Medical Center 
vivarium for the duration of the study. Upon arrival, all mice were allowed to acclimate for 1 
week prior to induction. The mice were housed in groups of 4 in ventilated cages; food and water 
was available ad libitum.  
The EAE study includes data from 3 cohorts of mice. Immunocytochemistry was 
performed on cohorts 1 and 2 (n=24 total), while cohort 3 (n=9 total) was used for western blot 
analysis and qRT-PCR. The LPS study includes mice from 1 cohort (n=22 total), which were all 
used for immunocytochemistry. Mice in all cohorts were maintained under the conditions as 
described above.  
EAE Induction 	
In order to model the inflammatory aspects of Multiple Sclerosis, we induced EAE as 
described in Clark et al. (2016). Twelve week old mice received a subcutaneous injection 
between the shoulders of a cocktail consisting of an equal volume of MOG (6 mg/ml peptide in 
PBS, amino acid 35-55) (AnaSpec, Inc., Fremont, CA) and Freunds’s complete adjuvant (heat 
killed M. tuberculosis dissolved in mineral oil; 10 mg/ml M. tuberculosis in Freund’s 
adjuvant)(Invitrogen Life Technologies, Grand Island, NY). Final concentrations are 3mg/ml 
MOG and 5 mg/ml complete Freund’s adjuvant (M. tuberculosis/Freund’s adjuvant). Mice also 
received an intraperitoneal (i.p.) injection of Pertussis toxin (300ng in 200ul of PBS/ mouse) 
(List Biological Labs, Campbell, CA). Mice received this pertussis toxin injection again 48 hours 
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later. Symptoms were scored based on a clinical score ranging from 0-5 as follows: 0 = no 
symptoms; 1 = limp tail, 2 = loss of righting reflex, 3 = single hind limb paralysis, 4 = both hind 
limbs were paralyzed, and 5 = death (Table	1).  
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Table 1. Clinical scoring criteria. Animals were evaluated daily and assigned clinical scores 
based on symptoms to track the severity of EAE.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical	Score	 Symptoms	
0	 None	
	
1	 Limp	tail	
	
2	 Limp	Tail	with	loss	of	righting	
reflex.	
	
3	 Paralysis	of	single	hind	limb.	
	
4	 Paralysis	of	both	hind	limbs.	
	
5	 Death.		
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Clinical symptoms were first observed approximately 7-10 days post injection with a 
progressive disease course that typically peaked by 12-14 days post injection (Figure	3). Only 
mice that reached and maintained a clinical score of 3 and 4 were used in this study. Although 
typical disease course results in mice reaching and maintaining clinical scores of 3 and 4, the 
disease is highly variable. Not all mice developed symptoms or maintained clinical scores of 3 or 
4. Mice were weighted daily and mice that lost >20% of their body weight were euthanized.   
This study focused on mice at two time points, Late EAE and Chronic EAE. Late EAE is 
defined as 9 days past peak clinical score (a clinical score of 3 or 4 is defined as peak) and 
Chronic EAE is 9 days past Late EAE. Mice were treated with Didox for 8 days.  Treatment was 
initiated the day following Late EAE, continued for 8 days, and mice were taken for analysis at 
the Chronic EAE time point (the morning following day 8 of treatment). Chronic EAE mice that 
received treatment with Didox will be known as “Didox”, and the untreated mice will be referred 
to as “Chronic EAE”. Only mice that maintained a peak score for 9 days (Late EAE) were 
included in the study (Figure	3, Table	2) 
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Figure 3. EAE experimental design. EAE is induced (A) and animals typically take ~10 days 
to start displaying clinical symptoms. Animals progress to peak clinical score (B), defined as a 3 
or 4, within a week of displaying clinical symptoms. Animals must maintain a clinical score of 3 
or 4 for 9 days to reach the Late EAE time point (C). Animals are divided into untreated 
(Chronic EAE) or treated with Didox for 8 days (Didox). Animals were harvested at the Chronic 
EAE time point (D). Note: all time points are defined by peak clinical score (C), which varies 
with every animal. Relative time points are represented on this graph.  
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Exclusion	Criteria: 
ØMouse	did	not	develop	a	clinical	score.	
ØMouse	developed	a	clinical	score,	but	recovered	(returned	to	
a	score	below	a	3	or	4)	at	any	time	before	reaching	Late	EAE.		
Table 2. EAE exclusion criteria. Only mice that reached the Late EAE time point were included in this study. 
Mice had to develop and maintain a clinical score of 3 or 4 for a period of 9 days in order to be included in the 
study.  
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Chronic EAE Didox Treatment 	
A cocktail of carboxymethylcellulose (0.5% w/v), sodium chloride (0.9%), polysorbate 
(0.4% w/v), and benzyl alcohol (0.9% w/v), all dissolved in deionized water, was used as the 
vehicle for Didox delivery and vehicle control. This cocktail is referred to as 
carboxymethylcellulose (Carboxy). In the EAE studies, Didox was administered at a dose of 
550mg/kg in 200µl of carboxymethylcellulose. Didox was administered daily via oral gavage, 
beginning at Late EAE and continuing for 8 days.  
The dosage, route of administration, and choice of vehicle have been previously 
established (Clark et al., 2016).  
LPS-mediated Inflammation 	
 LPS-mediated inflammation was also used to model aspects of CNS inflammation. Based 
on previous results from our lab, time points were defined to be analogous to those used in the 
Chronic EAE study and included 1 week post-LPS (1 Week LPS) and 2 weeks post-LPS (2 
Week LPS). At the 1 Week LPS time point, saline control and 1 Week LPS mice were taken for 
analysis. The remaining mice were divided into groups to receive Didox (Treatment, Didox was 
dissolved in saline) or saline (vehicle control) treatment beginning the day following the 1 Week 
time point. Treatment continued daily for 8 days and mice were harvested at the 2 Week LPS & 
Didox time point 16 days post-injection (Figure	4).  
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Figure 4. LPS experimental design. Based on previous results from our lab, time points were 
defined to study a prolonged model of LPS-induced inflammation. Mice received a single 
injection of LPS (5mg/kg) or saline (A). 1 Week post-injection, saline control and 1 Week LPS 
mice were taken for analysis (B).  The remaining mice were divided into groups to receive Didox 
or vehicle control saline treatment beginning the morning following the 1 Week time point.  
Similarly to the EAE studies, treatment continued for 8 days (D). Didox (treated) and 2 Week 
LPS (vehicle control) mice were harvested 16 days post-injection for analysis. 
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16 mice received a single i.p. injection of LPS (Millipore, Billerica, MA) dissolved in 
saline at a dose of 5mg/kg, and 6 mice received a saline injection alone (control). Mice were 
monitored every 3 hours for the first 12 hours and then every 12 hours until 48 hours after 
injection. LPS injected mice exhibit a variety of symptoms including hunched posture, lethargy, 
head pressing, weight loss (not more than 20%) and dehydration. Mice were given 300µl of 
sterile 0.9% saline subcutaneously to maintain hydration and transgel (Bioserve Biotechnologies, 
Beltsville, MD) was made available ad libitum. Mice were euthanized if weight loss exceeded 
20%.   
LPS Study Didox Treatment   
2 Week LPS + Didox (treatment, referred to as: Didox) mice received i.p. injections of 
Didox (Molecules For Health Inc., Richmond, VA) at a dose of 250mg/kg dissolved in 200µl of 
0.9% saline daily for 8 days and were taken for analysis on the 9th day. 2 Week LPS + Saline 
(vehicle control, referred to as: 2 Week LPS) vehicle control mice received 200µl of saline for an 
equivalent period of time. Control mice received saline injections at the beginning of the study 
and were taken for analysis at the 1 Week time point.  
Immunocytochemistry 
Tissue Preparation 	
Treatment was continued for 8 days past the peak clinical score. On the morning of the 9th day, 
mice were deeply anesthetized using a solution of 2.5% avertin (2,2,2-tribromoethanol)(Sigma-
Aldrich, St. Louis, MO). The avertin was in solution with 0.9% saline (Sigma-Aldrich) and 
administered at a dose of 0.016 mL/g of body weight. Mice were then transcardially perfused for 
10 minutes with 4% paraformaldehyde (Ted Pella, Redding, CA), as described in Clark et al. 
2016. Following perfusion, the brain was removed and placed in a solution of 30% sucrose in 
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Phosphate Buffered Saline (PBS) (137mM NaCl, 10mM Na2HPO4, 1.8mM KH2PO4, 2.7mM 
KCl; this solution will be referred to as 1X PBS) for 48 hours to cryopreserve the tissue prior to 
freezing. The cerebellum was removed with a razor blade and discarded. The brain was then 
placed in optimal cutting temperature (OCT)(Tissue-Tek, Sakura Finetek USA, Inc., Torrance, 
CA) media and transferred to a -80°C freezer for preservation. After at least 4 hours in the 
freezer, the samples were sectioned on a Leica CM 1850 cryostat (Leica Biosystems, Buffalo 
Grove, IL). Sections were serially cut at a thickness of 40µm in the coronal plane. Sectioning 
began 2.5mm posterior to bregma and finished 1.1mm anterior to bregma. The sections were 
serially placed on 15 slides, starting with slice #1 on slide 1, then slice #2 on slide 2, and 
continuing for 15 slides. Slice #16 was placed in position two on slide 1, and so on until there 
were 6 sections per slide.  Using this method, a single slide comprised a sample of ~3.0mm of 
cortex, with each section being ~600µm from each neighbor on a slide. All sections were stored 
at -80℃ until they were used for immunolabeling.  
Immunocytochemistry protocol  	
Slides were immunolabeled with antibodies directed against Ankyrin-G 
(AnkG)(NeuroMab, Davis, CA), βIV spectrin (kindly provided by Dr. Matthew Rasband, Baylor 
College of Medicine, Houston, TX), and Ionized calcium binding adapter molecule-1 (IBA-1) 
(Wako Chemicals; Richmond, VA). 
First, the slides were selected and defrosted on the lab bench. Excess OCT was removed 
with a razor blade and a hydrophobic barrier was drawn around the perimeter of the slides with a 
PAP pen (Sigma-Aldrich, St. Louis MO). The slides were then placed in cold acetone for 10 
minutes at -20℃ in order to permeabilize the tissue. After this initial acetone wash, the slides 
were washed three times for 5 minute each in 1X PBS. After the final wash, the hydrophobic 
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barriers were blotted dry and a blocking and permeabilizing solution composed of 1X PBS, 0.5% 
Triton X-100 (MP Biomedicals, Solon, OH), and cold-water fish gelatin (Electron Microscopy 
Services, Hatfield, PA) was pipetted onto the slides. The slides then sat in a sealed, opaque box 
for 15 minutes at room temperature. After this initial block slides were tilted and a pipette was 
used to remove the blocking solution. Then the hydrophobic barrier was blotted to remove 
residual liquid and the primary antibody solution was added. The following primary antibodies 
were used: 
Ankyrin-G 
Axon initial segments were visualized using Ankyrin-G mouse monoclonal IgG2a 
antibodies from NeuroMab (Davis, CA, clone N106/36). This antibody was generated against a 
synthetic peptide of 1000 amino acids from the Ankyrin-G protein. Detailed information on the 
location of this sequence within the Ankyrin-G molecule was not provided by the manufacturer. 
Using the National Library of Medicine’s Basic Local Alignment Search Tool (BLAST), I 
compared the polypeptide sequence used to generate the monoclonal antibody to the full 
Ankyrin-G polypeptide sequence. BLAST analysis showed that the monoclonal antibody 
sequence is 98% identical to amino acid 873-1477 of AnkG 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). This stretch of amino acids encompasses the unique 
intracellular spectrin binding domain of Ankyrin-G (Kizatail, 2006). The Ankyrin-G antibody 
was used in a concentration of 1:200 diluted in the previously described blocking solution.  
 
IBA-1 
Microglia were visualized for qualitative analysis with a rabbit polyclonal IgG antibody 
generated against ionized calcium binding adaptor molecule 1 (IBA-1)(Wako Chemicals USA, 
Richmond VA ). IBA-1 was used in a concentration of 1:1000. This polyclonal antibody is 
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generated against the C-terminal domain of IBA-1 and is commonly used to visualize the 
morphology of microglia (Clark et al 2016, Elmore 2015, Davalos 2012). 
NeuN 
A mouse monoclonal antibody against the neuronal nuclear protein (NeuN)(Millipore, Billerica, 
MA) was used to compare neuron nuclei number between treatment groups. NeuN was used at a 
concentration of 1:500. NeuN marks most neuronal nuclei, excluding cerebellar purkinje cells, 
olfactory bulb mitral cells, and retinal photoreceptor cells (Mullen et al., 1992).  
Secondary Antibodies 	
After the primary antibody(ies) were added to the slides, the slides were placed back in 
the sealed box in a 4 ℃ refrigerator overnight. The following day, slides were quickly placed in 
1X PBS to remove the primary antibody solution, and then washed three times in 1X PBS and 
blocked as previously described. After this block, the appropriate fluorescently labeled 
secondary antibodies were added and the slides incubated at room temperature in this solution 
for 90 minutes. An “appropriate” secondary antibody is one that is generated against the host 
species of the primary antibody. For example, since the monoclonal AnkG antibodies were 
generated in a mouse and were isotype IgG2A, the secondary antibody used to label the primary 
antibody was generated in a goat against mouse IgG2a.  
All fluorescently labeled antibodies were purchased from Thermo Fisher Scientific 
(formerly: Life Technologies; Waltham, MA) and were used at a concentration of 1:500. After 
the secondary incubation, the slides were drained and the nuclear marker bis-Benzimide (Sigma-
Aldrich, St. Louis MO) was added to the slides at a concentration of 1:1000 (diluted in 1X PBS) 
for 2 minutes. The slides were again washed three times for 5 minutes in 1X PBS and 
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coverslipped using the anti-fade reagent Vectashield™ (Vector Laboratories, Burlingame, CA), 
and placed in a slide box at 4℃ until imaging.  
Microscopy and Image Quantification 
Chronic EAE 	
All images were collected using a Zeiss LSM 710 confocal laser scanning microscope 
(Carl Zeiss Microscopy LLC, Thornwood, NY), located in the Virginia Commonwealth 
University (VCU) Department of Anatomy and Neurobiology Microscopy Facility. Images for 
Ankyrin-G, and IBA-1 quantitation were taken from layer V of the neocortex as confocal z-
stacks. Each image was 215µm tall, 215µm wide, and spanned an optical depth of 25µm. These 
dimensions define a field of view (FOV). Images were taken with a 40X oil immersion objective 
with a numerical aperture of 1.3, an optical slice thickness of 1.0µm and a scan average of 2; and 
1 Airy unit. Gain, offset, and laser power were kept constant for all images (Table	3, A).  
 Ankyrin-G quantitation 	
Four images were collected from each of the six sections on a slide. Two images from 
cortical layer V of the left hemisphere, and two from cortical layer V of the right hemisphere, 
giving a total of 24 images per mouse. Neocortical layer V was identified based on the sparse 
nuclei distribution (visualized through bis-benzamide nuclear staining) of layer V when 
compared to the more tightly packed nuclei of layer IV and layer VI. Ankyrin-G was quantified 
manually as described below.  
NeuN quantitation 	
 NeuN staining was visualized for Neuron viability. A sample of 3 mice were taken from each 
treatment group (3 Naïve, 3 Late EAE, 3 Chronic EAE, and 3 Didox) for NeuN quantification. A 
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single optical slice was taken from layer V of each hemisphere on slice 2 from each slide (2 
images per slide). This yielded approximately 250+ cells per image or 500+ cells per 
slide.  Microscope settings were kept constant for EAE NeuN quantitation (Table	3, B). These 
images were processed and quantified using the automated counting method described in 
Chapter 6 to count the cells per image.  
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Table 3. Zeiss LSM 710 microscope settings for the Chronic EAE study. Ankyrin-G, IBA-1, and NeuN 
were collected using consistent settings on the Zeiss 710 Laser Scanning Confocal Microscope. All images 
were collected at the VCU Microscopy Facility.  
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LPS-mediated Inflammation 	
For the LPS study, an identical procedure was used, except one image was taken from 
each hemisphere on each slice, yielding 12 images per mouse. Microscopy settings were kept 
constant for all quantitated images in LPS-mediated inflammation (Table	4, A).  
NeuN quantification 	
NeuN staining was visualized for Neuron viability. A sample of 3 mice were taken from each 
treatment group (3 Controls, 3-1 Week LPS, 3-2 Week LPS, and 3 Didox) for NeuN 
quantification. A single optical slice was taken from layer V of each hemisphere on slice 2 from 
each slide (2 images per slide). This yielded approximately 250+ cells per image or 500+ cells 
per slide. Microscope settings were kept constant for EAE NeuN quantitation (Table	4, B). 
These images were also processed and quantified in the same manner as NeuN quantitation for 
the Chronic EAE study.  
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Table 4. Zeiss LSM 710 microscope settings for LPS-mediated inflammation study. Ankyrin-G, IBA-
1, and NeuN were collected using consistent settings on the Zeiss 710 Laser Scanning Confocal 
Microscope. All images were collected at the VCU Microscopy Facility.  
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Image Quantification 	
For the EAE study, the length and quantity of initial segments in each image, or field of 
view (FOV; a field of view consists of an area 215.04µm X 215.04µm X 25µm), were 
determined using the manual tracing function on the ImageJ analysis software in a manner 
previously described in Clark et al. (2016). Maximum intensity projections were created in 
ImageJ from the optical stacks and the initial segments of each image were traced and measured. 
To eliminate the counting of AISs that extended beyond the boundaries of the FOV, any AIS 
touching one of the 6 edges of the optical stack was not traced or counted. Microsoft Paint 
(Microsoft, Redmond, Washington) was used to mark any AISs that appeared in the very first, or 
in the very last optical slice before they were compressed into a maximum intensity projection. 
Once the slices were compressed on ImageJ, a mark was visible on any initial segments that 
were not completely contained in the image stack. These initial segments were excluded from 
quantification. Ankyrin G labeling measuring less than 10µm in length were excluded from both 
counts and length measurements, as described in Schafer et al. (2009).  
  AIS counts and lengths were collected by FOV per mouse. For quantifying AIS number, 
the AISs per field of view were recorded, and an average was calculated per FOV for that mouse. 
This allowed an average number of AISs per FOV for each mouse in a treatment group to be 
calculated. Once these numbers were established for mice in a treatment group, the groups were 
compared based on % of Naïve ±standard error of the mean (SEM). 
AIS length was collected by measuring the manual traces on initial segments. The 
average length per FOV per mouse was calculated and mice were compared by treatment group. 
Results are presented as the average length in µm ± SEM.  
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Automated Quantitation 	
A method for automated quantitation of initial segments and neuronal nuclei was 
developed and used for the LPS-mediated inflammation portion of this study. For details of the 
automated procedure and an analysis of the automated technique compared to manual counting 
methods, see Chapter 6.  
Western Blots 
Tissue Processing 	
Western Blotting was performed as previously described (Pomicter et al., 2010). Mice 
were deeply anesthetized with Avertin; the brain was dissected and the cortex was removed, 
placed in centrifuge tubes, flash frozen in liquid nitrogen, and stored at -80℃. For 
homogenization, frozen neocortices were placed in RIPA buffer (1% nonidet P40, 0.5% Sodium 
deoxycholate, 0.1% sodium dodecyl sulfate, and 1X PBS)(Sigma-Aldrich, St. Louis, MO) 
containing protease inhibitor cocktail (PIC) (Sigma-Aldrich, St Louis, MO). RIPA buffer with 
PIC is used to cause cell lysis and minimize protein degradation. 2ml of RIPA buffer with PIC 
was added to each sample’s conical tube and the samples were homogenized with a Glas-col 
motor driven homogenizer (Terre Haute, IN, USA) at a speed of 60 for 10 strokes (a stroke is 
defined as the pastel moving from the top of the Eppendorf tube to the bottom, then back to the 
top). After homogenization, the samples were centrifuged at 2911 revolutions per minute (RPM) 
for 10 minutes at 4℃. Supernatants were collected and transferred to labeled microcentrifuge 
tubes, which were stored at -20℃.  
Protein Assay 	
Supernatant protein concentration was determined using the Micro BCA Protein Assay 
Kit (Thermo Scientific, Rockford, IL) in order to ensure equivalent protein loading for western 
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blot gel electrophoresis. From the manufacturer’s protocol (Thermo Scientific Rockford IL; 
Thermo # 23235): Bovine serum albumin (BSA)(Thermo Scientific, Rockford, IL) was serially 
diluted with 1X PBS to create eight standards (labeled S1-S8, with concentrations 2mg/ml, 
1.5mg/ml, 1mg/ml, 0.75mg/ml, 0.5mg/ml, 0.25mg/ml, 0.125mg/ml, and 0.025mg/ml 
respectively) and a “blank” that contained PBS without BSA. 25µl of each of the BSA standards 
and the blank were added to a 96 well plate in duplicate. 10µl of the tissue sample supernatant 
was then diluted in 100µl of 1X PBS, and added to the same 96 well plate in duplicate below the 
standards. The BCA assay kit reagents A, B, and C were mixed at a ratio of 25:24:1 and 200µl of 
the resulting solution was added to each of the occupied wells. The plate was then incubated at 
37℃ for 15 minutes and cooled before being read in a spectrophotometer. A standard curve was 
generated using the sample absorbance values and used to determine protein concentrations of 
the samples.  
Western Blot Protocol: 	
Protein concentrations determined from the BSA Protein Assay were normalized by 
diluting with sample buffer (Laemmli Sample buffer, β-mercaptoethanol 20:1) to ensure a 
standard 20µg load of protein per lane. The diluted samples were then boiled for 5 minutes and 
immediately placed on ice. After cooling, they were briefly centrifuged for 2 minutes at 10,000 
RPM, and 10µl of solution containing 20µg of protein was added to a in a precast Criterion ™ 
TGX ™ 10 well gel (4-15% polyacrylamide; Bio-Rad, Hercules, CA). 10µl of molecular weight 
marker (Bio-Rad, Hercules, CA; Precision Plus Protein ™ Kaleidoscope ™) was added to the 
first lane as a standard weight measurement. The Western blot apparatus (Bio-Rad Mini Protean 
Tetra cell; Bio-Rad, Hercules, CA) was filled with running buffer (100 mL of 10X Tris-Glycine 
(0.25M Tris; 1.92M Glycine (Thermo Fisher Scientific Waltham, MA), 1g of Sodium dodecyl 
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sulfate, and 900 mL of deionized water), and the gel was set to run at 70V for 30 minutes 
initially, then at 100V for an additional hour. The gels were then removed, placed in transfer 
buffer (10X Tris-Glycine, 20% Methanol (Thermo Fisher Scientific Waltham, MA)), and were 
rocked in this solution for 15 minutes. A nitrocellulose membrane was cut to fit the gel and 
rocked in a transfer buffer for 15 minutes as well. A transfer cassette was prepared by 
sandwiching the sample gel and nitrocellulose paper between 2 blotting papers and 2 sponges. 
This transfer cassette was then placed in a gel box under ice, and connected to a power supply at 
100V for 2 hours. Following the transfer, the gel was discarded and the nitrocellulose paper was 
washed in PBST (1X PBS and 0.05% Tween (Thermo Fisher Scientific Waltham, MA)) and 
incubated with a blocking solution composed of 3% non-fat dry milk (Nestle, Switzerland) and 
PBST for 40 minutes. The membrane was incubated overnight in a primary antibody blocking 
solution at 4℃.  
Rabbit polyclonal anti-βIV Spectrin was used to probe for the AIS cytoskeletal 
component βIV spectrin. This antibody was used at a concentration of 1:2000 and was 
generously provided by Dr. Matthew Rasband of Baylor College of Medicine.  
A mouse monoclonal antibody against inducible nitric oxide synthase (iNOS)(BD Biosciences, 
San Jose, CA) was used at a concentration of 1:2000 to quantify protein expression of this 
inflammatory marker. iNOS is often elevated in MS, EAE, and LPS-induced inflammation 
(Valentin-Torres 2016, Hu 2016, Kipp 2016, Taetzsch 2015). 
Mouse anti-GAPDH antibody (Millipore, Billerica, MA) was used at a concentration of 
1:10,000 as a loading control for all western blot experiments.  
Two methods were used for visualizing proteins on western blot experiments: 
chemiluminescence, and fluorescent secondary antibodies.  
	 45	
Chemiluminescence 	
The following day, the nitrocellulose membrane was washed in PBS 3 times, for 10 
minutes each, blocked for 20 minutes, and incubated in a secondary antibody solution for 1.5 
hours before imaging. Western blots were finished with horseradish peroxidase conjugated 
secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). These antibodies were Goat-
anti-mouse for iNOS and GAPDH, and Goat-anti-Rabbit for βIV spectrin. The secondary 
antibodies were diluted 1:10,000 in blocking solution. StrepTactin-HRP (Santa Cruz 
Biotechnology, Santa Cruz, CA) was also added to the secondary antibody solution to visualize 
the ladder. Following a 1.5 hour incubation, enzyme chemiluminescence reagents (Millipore, 
Billerica, MA) reagents were combined in a 1:1 ratio and the blot was imaged in a Bio-Rad 
ChemiDoc Touch® imaging system (Bio-Rad, Hercules, CA).  
 Fluorescent Secondary Antibodies 	
The following day, the nitrocellulose membrane was washed in PBS 3 times for 10 
minutes each wash, blocked for 20 minutes, and incubated in a secondary antibody solution for 
1.5 hours. The secondary antibody solution was composed of IRDye® 800CW Goat anti-Rabbit 
and IRDye® 680RD Goat anti-Mouse. These fluorescent antibodies were both purchased from 
LI-COR (Lincoln NE) and used at a concentration of 1:15000. After the incubation, the 
nitrocellulose paper underwent two 5 minute washes in PBST followed by four 10 minute 
washes in PBS alone. The nitrocellulose blots were then read on a LI-COR  Odyssey® Infrared 
Imaging System (Lincoln NE) for quantitative analysis. 
Densitometry 	
Western blot bands were analyzed using ImageJ (NIH). Lanes were selected and band 
densities per lane were graphed by the Analyze Gels Plugin. The area under the curve (optical 
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density) was determined using the wand tool (Pomicter et al., 2010). This process was repeated 
and the values recorded for each protein of interest and each loading control. The optical density 
of each protein of interest was then divided by the optical density of the respective loading 
control (GAPDH) to yield a relative quantity.  
Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) 
RNA extraction 	
Total RNA was extracted from mouse cortices using a trizol (Ambion Invitrogen, 
Thermo Fisher Scientific Waltham, MA) homogenization and extraction method described in 
Taetzsch 2014. Mice were deeply anesthetized with Avertin and perfused with 0.9% NaCl; the 
brain was dissected and the cortex was removed, placed in microcentrifuge tubes, flash frozen in 
liquid nitrogen, and stored at -80℃. Brain cortices were homogenized with a Glas-col motor 
driven homogenizer (Terre Haute, IN, USA) in 1mL of trizol. Samples were centrifuged at 
12,000xg for 10 minutes at 4℃. Supernatant was collected and samples sat at room temperature 
for 5 minutes. 200µl of chloroform (Thermo Fisher Scientific Waltham, MA) was added to the 
samples and mixed by inversion. Samples sat for 10 minutes at room temperature before being 
centrifuged at 12,000xg for 15 minutes at 4℃. The aqueous phase was transferred to a new 
microcentrifuge tube and an equal amount of 100% isopropanol (VWR Chemicals, Randor, PA) 
was added. Samples were mixed by inversion and placed at room temperature for 10 minutes, 
and centrifuged  at 12,000xg for 15 minutes at 4℃. The supernatant was removed and the RNA 
pellet was washed twice with 75% ethanol (VWR Chemicals, Randor, PA) and  homogenized. 
Samples were centrifuged at 7500xg for 5 minutes at 4℃  and the pellet was air dried for 10-15 
minutes before being re-suspended in 100µl of DEPC water. 
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RNA Purification 	
RNA samples were purified using the Qiagen RNeasy kit (Qiagen, Venlo, Netherlands) 
according to manufacturer’s instructions. Briefly, 350µl of Qiagen buffer RLT was added to 
100µl of RNA and mixed by inversion. 250µl of 100% ethanol (VWR Chemicals, Randor, PA) 
was added to the RNA and this solution was mixed by pipetting. The samples were transferred to 
RNeasy spin column and placed in a 2ml collection tube. Samples were centrifuged for 15s at 
8000xg. 500µl of buffer RPE was added to the RNeasy column and centrifuged at 8000xg for 2 
minutes. After this centrifugation step, the spin column was transferred to a new collection tube 
and centrifuged at 16,000xg for 1 minute. RNA was eluted using 30µl of RNase free water and a 
1 minute centrifugation at 8000xg. 
DNase Treatment 	
First, RNA concentration and purity was measured using a nanophotometer and only 
samples with an absorbance ratio (260nm/280nm) >1.8 were included (Implen GmbH, 
Germany). An Ambion DNA Free Kit (Thermo Fisher Scientific Waltham, MA) was then used 
to remove contaminating DNA. 12µl of DNase was added to each sample and then samples were 
incubated for 30 minutes at 37℃. After this incubation, 10µl of DNase inactivation reagent was 
added to each sample. Samples were then incubated for 2 minutes at room temperature. Samples 
were centrifuged at 10,000xg for 1.5 minutes and the supernatant collected. 
Reverse Transcription 	
iScript Reverse Transcription Supermix (BioRad, Hercules, CA) was used to create 
cDNA from sample RNA. Samples were prepared with 4µl of BioRad 5X iScript supermix 
followed by 16µl RNA sample in a 100µl Veriti Thermal Cycler tube (Thermo Fisher Scientific 
Waltham, MA) and mixed by repeated pipetting. A no reverse-transcriptase (RT) control was 
	 48	
prepared by adding 16µl of RNA from a sample (Late EAE sample) to 4µl of no- reverse 
transcriptase BioRad 5X iScript supermix. Samples and the no-RT control were spun down and 
placed in an Applied Biosystems Veriti Thermal Cycler (Thermo Fisher Scientific Waltham, 
MA) set to run for 5 minutes at 25℃, 30 minutes at 42.5℃, and 5 minutes at 85℃. Samples 
were then stored at -20℃. 
qPCR 	
Primers were designed for iNOS, TNFα, and the housekeeping gene cyclophilin A 
(Cyclo A) using the National Center For Biotechnology Information (NCBI) website (Error! 
Reference source not found.). These primers were previously used in the lab (Clark et al., 
2016). Samples were run with each primer in duplicate. A no-RT control and a no-template (no 
cDNA, containing just water) control was also run for each primer set. Master mixes were 
prepared for 19µl per well for the target and reference gene. 10µl of BioRad SsoFast Evagreen 
Supermix (BioRad, Hercules, CA) was combined with 0.5µl of the forward primer (primer 
concentration is 20µM), 0.5µl of the reverse primer, and 8µl of DNase free water. The master 
mix contains a final primer concentration of 500nM. Master mixes were prepared, mixed and 
spun down for target and control genes. Master mix was then added to the appropriate wells of a 
96 well plate and 1µl/well of sample cDNA was added. The plate was sealed and run in a 
BioRad thermal cycler at the following cycling parameters: one cycle at 95℃ for 5 minutes, 40 
cycles of 95℃ (5s) and 56℃ (5s) followed by the generation of a melt curve through a series of 
5 second 0.5℃ incremental temperature increases from 65℃ to 95℃.. The fold changes in the 
expression of target genes were calculated using the formula RQ=2-ΔΔCt. 
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Table 5. qRT-PCR primer sequences. TNF𝛂, iNOS, and Cyclo A primers were designed using 
the NCBI website.  
 
 
 
 
 
 
 
 
 
 
Gene Primers 
TNF𝛂 Forward: 5’-GCCCACGTCGTAGCAAACCACC-3’ 
 Reverse: 5’ -CCCATCGGCTGGCACCACTA-3’ 
iNOS Forward: 5’ -TCCAGAATCCCTGGACAAGCTGC-3’ 
 Reverse: 5’-TGCAAGTGAAATCCGATGTGGCCT-3’ 
Cyclo A Forward: 5’-CTAGAGGGCATGGATGTGGT-3’ 
 Reverse: 5’- TGACATCCTTCAGTGGCTTG-3’ 
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Statistical Analysis 
 
To compare the number of initial segments, the data are presented as percent of naïve (% 
naïve ± standard error of the mean (SEM). To compare AIS length, the average length of the 
AISs (in μm) is presented as mean length ± SEM. Mice were averaged and compared by 
treatment group with one-way analysis of variance (ANOVA) and Tukey’s Honest Significant 
difference (HSD) post hoc test. When appropriate, t-tests were used to compare two groups 
independently. All graphing and statistical analyses were performed using GraphPad Prism 
version 6.03 for Windows or OSX (GraphPad Software, San Diego, CA, USA). For western blot 
experiments, an average was computed per treatment group and the values were compared using 
one-way ANOVA. qRT-PCR data was analyzed in the same manner.  
Data was processed from the automated analysis technique using the R programming 
language (R Core Team, 2015) but statistics were performed using GraphPad Prism. Along with 
base R functions, the following packages were used for organizing and summarizing data: 
ggplot2 (Wickham, 2009), reshape2 (Wickham, 2007), and dplyr (Wickham and Francois, 2015). 
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Chapter 3: Chronic EAE Results 
 
AIS numbers are reduced in Chronic EAE 
To investigate the effect of prolonged inflammation on AIS stability, initial segments 
were analyzed in Naive, Late EAE, Chronic EAE, and Chronic EAE + Didox (Didox) animals. 
Initial segments were quantified by manual tracing in ImageJ for the EAE studies. In Late EAE 
mice there was an average loss of 37±10.4% of initial segments compared to naive controls, and 
mice at the Chronic EAE time point displayed an average loss of 43.5±11.6% of AISs. Mice 
treated with anti-inflammatory Didox displayed a loss of 21.9±8.9% of initial segments 
compared to naive controls. Although there appears to be a decrease in initial segment numbers 
at the Late and Chronic EAE time points and a recovery with Didox treatment, one-way 
ANOVA indicates that there is no significant difference among groups (Figure	5).  
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Figure 5 AIS number and length in Chronic EAE. The number of AISs are decreased by 37% at the Late EAE (B) 
time point compared to Naïve controls (A,E). There is a 43.5% decrease in AISs at the Chronic EAE (C,E) time point 
and a 21.9% loss following treatment with Didox (D,E). Despite these changes, results were not significant following 
one-way ANOVA. Average AIS length was unchanged during these time points (F) (n=4-8 at each time point, scale 
bar = 20µm). 
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AIS Length is not different in Late and Chronic EAE 	
In previous studies from our laboratory, we have reported a significant shortening of 
AISs at the early EAE time point, followed by a significant loss in AIS number at the late EAE 
time point. To determine if the significant shortening of the AISs was preserved in the chronic 
disease stage, we measured AIS length in Naive, Late EAE, Chronic EAE, and Didox mice. No 
significant difference in AIS length was detected. Naive mice displayed an average length of 
16.4±0.2µm, Late EAE mice displayed an average of 15.5±0.3µm, Chronic EAE mice displayed 
an average of 16.5±0.5µm and Didox mice displayed an average of 16.1±0.3µm (Figure	5). 
Neuron cell count is not changed in Late or Chronic EAE 
 
In order to determine if the apparent reduction in AIS number was a consequence of 
neuron cell loss, sections were immunolabeled with NeuN, a marker of neuronal nuclei, and the 
numbers were quantitatively compared among the Naive mice and all treatment groups. An 
average NeuN+ cell count of 262.5±8.8 NeuN+ cells (NeuN+)/ FOV in Naive mice, 275.7±11.8 
NeuN+/FOV in Late EAE, 262.2±16.3 NeuN+/FOV in Chronic EAE, and 275.3±18.8 
NeuN+/FOV in Didox was detected. There was no significant difference in neuronal counts 
between treatment groups (Figure	6).   
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Figure 6. NeuN+ nuclei loss is not detected in Chronic EAE. NeuN was used to label neuronal nuclei in Naïve 
(A), Late EAE (B), Chronic EAE (C), and Didox (D) animals. Group means were compared using one-way 
ANOVA. No significant changes were detected (E) (n=3 mice at each time point, scale bar= 50µm). 
	 55	
Microglia display a less reactive morphology in Chronic EAE 
 
In our previous work, we identified microglia, the resident immune cells of the CNS, as a 
candidate driver of AIS pathology. To begin to assess the inflammatory environment within the 
cortex, microglia were identified by IBA-1 immunolabeling and cell morphology was 
qualitatively compared among groups. Qualitative analysis of microglia morphology revealed 
that microglia are reactive in Late EAE, but show decreased reactivity in both Chronic EAE and 
Didox animals, as microglia with surveying phenotypes were readily observed in these mice 
(Figure	7). These observations are consistent with a reduced inflammatory environment in both 
Chronic EAE and Didox treated animals. 
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Figure 7. Microglia reactivity in Chronic EAE. Microglia display a ramified, 
surveying phenotype in Naïve mice (A). Microglia adopt a reactive morphology in Late 
EAE with larger cell bodies and shorter, thicker branches (B). Microglia reactivity 
decreases in both Chronic EAE and Didox mice (C and D)(scale bar= 20µm). 
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Inflammatory markers TNFα  and iNOS are increased in the EAE Cortex 	
Although morphological changes of the microglia were consistent with increased 
inflammation in Late EAE mice and an apparent resolution in the microglial morphology 
indicating a reduced inflammatory environment in the Chronic EAE and Didox mice, 
morphology is not always a reliable indicator of microglia function (Hanisch and Kettenmann, 
2007; Taetzsch et al., 2015). To further investigate the inflammatory environment within the 
cortex, qRT-PCR was used to assess the levels of two inflammatory markers, TNFα and iNOS. 
Target gene values were normalized to the housekeeping gene Cyclo A using the formula   
RQ=2-ΔΔCt to calculate fold changes in expression (Taylor 2010).  
Expression levels of TNFα were significantly increased in the cortices of Chronic EAE 
animals compared to Naïve controls (average of 6.9±1.1 in Chronic EAE and 0.6±0.2 in Naïve 
animals). Treatment with the anti-inflammatory Didox significantly decreased TNFα expression 
at the Chronic EAE time point (2.4±0.2 in Didox compared to 6.9±1.1 in Chronic EAE). Didox 
levels were not significantly different from Naïve (2.4±0.2 in Didox and 0.6±0.2 in Naïve 
animals)(Figure	8).  
iNOS expression was increased in Chronic EAE animals (average of 6±2.8 for Chronic 
EAE versus an average 1.2±0.2 for Naïve), and further decreased following treatment with 
Didox (average expression of iNOS with Didox treatment of 0.8±0.2 compared to 1.2±0.2 for 
Naive). Although there was a 6-fold increase in average iNOS expression levels, the groups were 
not significantly different from one another (Figure	9).  
Additionally, protein levels of the pro-inflammatory mediator iNOS were measured via 
western blot analysis and standardized based on the GAPDH loading control. Densitometry 
revealed no significant difference in immunoreactive iNOS bands between groups (Figure	10).  
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Figure 8. TNFα  mRNA levels are significantly increased in the cortex of Chronic EAE mice. 
Cortical mRNA levels of TNFα	in	Chronic	EAE	mice	were	elevated	7	fold	(6.9±1.1)	above	levels	measured	in	Naïve	mice	(0.62±0.2).	Didox	treated	animals	displayed	levels	of	TNFα	that	were	not	significantly	different	than	Naïve	(2.4±0.2)	(one-way	ANOVA,	p<0.01,	n=3	at	each	time	point). 
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Figure 9. iNOS mRNA Levels are Elevated in the Cortex of Chronic EAE Mice. Average cortical 
mRNA levels of iNOS rise in Chronic EAE mice relative to Naïve mice (compare Chronic EAE at 6± 
2.8 vs. Naïve at 1.2± 0.2) and decrease following treatment with Didox (Didox expression is 0.8±0.2). 
No statistical difference between treatment groups was detected (one-way ANOVA, n= 3 at each time 
point). 
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Figure 10. iNOS protein levels are not changed in Chronic EAE mice. Western blot analysis and 
densitometry of iNOS immunoreactive bands in cortical lysates revealed no significant change in 
protein levels of iNOS (one-way ANOVA, n=3 at each time point). 
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βIV spectrin protein levels are not altered in EAE 
 
Although vital for the initial setup of the AIS, Ankyrin-G is a relatively fast-changing 
portion of the initial segment with a half life of ~7 days in vitro (Hedstrom et al., 2008). βIV 
spectrin has an in vitro half life of ~2 weeks and is regarded as essential for both the function and 
long term stability of the initial segment (Hedstrom et al., 2008; Komada and Soriano, 2002; 
Yang et al., 2007). In order to further characterize the Chronic EAE model we also performed 
western blots analysis for βIV spectrin. Decreasing βIV spectrin protein levels in western blots 
concurrent with loss of Ankyrin-G observed in immunocytochemistry would indicate the loss of 
two key initial segment proteins and lend support to the idea of AIS breakdown in Chronic EAE.  
As previously reported, two bands were observed for βIV spectrin corresponding to the 
two alternatively spliced variants present at the initial segment (Berghs et al., 2000; Lacas-
Gervais et al., 2004; Yang et al., 2007). βIV spectrin Σ1, is the essential spectrin for AIS 
stability, was observed by western blot analysis and identified at ~250kD, while βIV spectrin Σ6 
was observed at ~150kD (Lacas-Gervais et al., 2004; Yang et al., 2007). Densitometry was 
performed and compared to GAPDH loading controls. Levels of βIV spectrin were not found to 
be significantly different in any of the experimental groups (Figure	11).  
In addition to showing a reduction of full length βIV spectrin in a stroke model, Schafer 
et al. (2009) reported the presence of a βIV spectrin breakdown product at ~45kD. The presence 
of this breakdown product would support AIS disruption. Therefore, we determined to use the 
presence or absence of this breakdown product to further assess βIV spectrin integrity. As shown 
in Figure	11, no difference in the intensity of βIV spectrin+ bands at the appropriate size was 
observed. 
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Figure 11. βIV spectrin protein levels are not changed in Chronic EAE mice. Western Blot 
Analysis and densitometry of βIV spectrin immunoreactive bands from cortical lysates revealed no 
significant change in protein levels of either of the alternatively spliced variants present at the initial 
segment (A,B,E,F). In addition, no difference in the intensity of visible bands was detected among any 
of the treatment groups at ~45kD (C). All protein levels are relative to the GAPDH loading control (D) 
(one-way ANOVA, n=3 at each time point). 
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Chapter 4: LPS Induced Inflammation Results 
 
LPS-mediated inflammation induces AIS shortening and loss which recovers at a chronic 
time point 
 
Our studies attempt to determine whether the effects of inflammation on AIS integrity are 
reversible. In order to determine the effects of inflammation on the AIS, we also employed the 
well-characterized model of inflammation called LPS-mediated inflammation. Unlike EAE, 
LPS-mediated inflammation follows a predictable physiological progression with limited 
variability among animals. Previous studies from our laboratory using the LPS-induced 
inflammation model have established that a single peripheral injection of LPS induces a 
significant rise in CNS inflammatory markers within 6 hours, and results in a significant 
decrease in AIS number by 24 hours post-injection (Benusa and Dupree, unpublished 
observations). This loss in AIS number persists through 1-week post LPS injection, and is 
accompanied by persistent cortical inflammation. Qualitative analysis of immunolabeling for 
CD4+ T-cells in the cortex indicates that there is not widespread T-cell infiltration in LPS-
mediated inflammation (Benusa and Dupree, unpublished observations).  
Animals were treated with the anti-inflammatory Didox beginning 1-week post LPS 
injection and AIS stability was analyzed 1 week later (2 weeks post-LPS injection). AIS 
quantitation, based on the automated counting method (see Chapter 6), revealed a significant 
reduction of initial segments in 1 Week LPS mice (34.7±5.1% average loss) compared to 
Controls. Surprisingly, AIS numbers were significantly increased back to control levels in 2 
Weeks LPS mice (12.9±2.7% loss) independent of anti-inflammatory Didox treatment (Figure	
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12, A-C, E). No significant change in the number of initial segments was detected with Didox 
treatment when compared to saline controls (8.1±2.7% loss) (Figure	12, A,D,E). However, AIS 
length analysis revealed a significant decrease at both the 1 Week LPS and 2 Week LPS time 
points (compare an average Control length of 16.8±0.4µm to 15.3±0.1µm for 1 Week LPS 
animals and 15.6±0.2µm for 2 Week LPS animals) (Figure	12, F). Didox treated animals 
displayed an average AIS length of 16.2±0.1µm, which is not significantly different from the 
average control length of 16.8±0.4µm. One-way ANOVA did not reveal a significant difference 
between Didox AIS length and 2 Week LPS length.  
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Figure 12. LPS-mediated inflammation induces significant loss of AIS number and length. AIS numbers are 
significantly reduced 1-week post LPS injection and recover independently of Didox treatment 2-weeks post 
injection (A-D, E). AIS length is significantly reduced 1-week post-LPS injection and remains shortened at the 2-
week time point. Average AIS length and number for Didox treated animals are not significantly different from 
Control (n=4-6 per treatment group, one-way ANOVA, p<0.05, scale bar=20µm).   
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Microglia display a less reactive morphology in 2 Week LPS animals. 
 
Since our hypothesis implicates reactive microglia as the driving force for AIS pathology 
following inflammation, we qualitatively assessed microglia reactivity based on morphology. 
Qualitative analysis of microglia morphology revealed that compared to Control animals, 
microglia are reactive in 1 Week LPS animals, but show decreased reactivity in both 2 Week 
LPS and Didox animals (Figure	13). This mirrors the EAE studies and is consistent with the 
possibility that microglia mediated inflammation may drive the observed changes in the initial 
segments.  
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Figure 13. Microglia reactivity in LPS-mediated inflammation. Microglia display a ramified, 
surveying phenotype in Control mice (A). Microglia adopt a reactive morphology in 1-Week 
LPS mice, displaying larger cell bodies and shorter, thicker, branches (B). Microglia reactivity 
decreases in 2-Week LPS and in Didox mice (C,D)(scale bar=20µm).    
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Neuron cell count is not changed in LPS-mediated inflammation.  
 
To determine if the reduction in AIS number was a consequence of neuron cell loss, brain 
sections were stained with NeuN. There was an average NeuN+ cell count of 242.3± 27.6 
NeuN+/FOV for Control mice, 228.3±18 NeuN+/FOV for 1 Week LPS animals, 244.5±26.2 
NeuN+/FOV for 2 Week LPS animals, and 232±20.8 NeuN+/FOV for Didox treated animals. 
There was no significant difference in NeuN+ cells among any of the treatment groups (Figure	14). 
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Figure 14. NeuN+ nuclei loss is not detected in LPS-mediated inflammation. NeuN was used to label neuronal 
nuclei in Control (A), 1 Week LPS (B), 2 Week LPS (C), and Didox (D) animals. Group means were compared using 
one-way ANOVA and no significant changes were detected (E) (n=3 at each time point, scale bar= 50µm). 
	 70	
Chapter 5: Discussion 
Changes in AIS number are observed in Chronic EAE, but these changes are not 
significant.  
 
 We have previously reported that initial segment length is significantly reduced in Early 
EAE, and this decrease in length is followed by a significant loss in the number of initial 
segments at the Late EAE time point. Treatment with the anti-inflammatory Didox led to a 
significant recovery in the number of initial segments present in Late EAE animals (Clark et al., 
2016). These results indicated an ability to ameliorate initial segment disruption. In the current 
study, we sought to test the ability of Didox to reverse the loss of initial segments at a time point 
when there had previously been a significantly loss. Here, we report an average initial segment 
loss of 37±10.4% at a Late EAE time point compared to naive controls, and mice at the Chronic 
EAE time point displayed an average loss of 43.5±11.6%. Mice treated with anti-inflammatory 
Didox displayed a loss of 21.9±8.9% when compared to Naive controls, or ~20% more initial 
segments than untreated animals. Although a trend to recover was noted in the Didox treated 
animals, the results for all groups were not significantly different from Naïve animals. The 
variability of the EAE model is highlighted by these results. The final analysis of initial segment 
number and length was composed of 8 Chronic EAE mice, 7 Didox mice, 4 Late EAE mice, and 
4 Naïve mice. Based on a power analysis to detect significance at a level of 0.95 and a power of 
0.80, a group size of 5 is required for all EAE time points. 	
Initial segments spontaneously recover in LPS-mediated inflammation 
 
LPS-mediated inflammation was used to investigate the effects of prolonged 
inflammation on the AIS independently of blood brain barrier breakdown and T-cell infiltration. 
Although the blood brain barrier is preserved following LPS injection, peripherally generated 
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inflammatory cytokines enter the CNS and facilitate an inflammatory response. Using this 
model, we observed a significant decrease of 34.7±5.1% in the number of initial segments 1 
week following LPS injection compared to Controls. Analysis at the 2 weeks post LPS time 
point revealed a significant restoration of AISs, with animals displaying a 12.9± 2.7% loss 
compared to Control. The extent of recovery in Didox treated mice was not significantly 
different from the non-treated mice (8.1± 2.7 loss compared to Control). These results indicate 
that there is spontaneous recovery of the initial segment 2 weeks post-LPS injection. These 
findings are highly significant in regard to the potential for AIS recovery. This study is the first 
to show that the loss of cortical initial segments can be reversed, with the literature stating that 
the loss of initial segments is irreversible (Schafer et al., 2009). These findings are potentially 
highly impactful for patients suffering from inflammatory diseases such as MS, as preliminary 
data indicates that cortical AISs are lost in this devastating disease (Figure	2). Interestingly, the 
anti-inflammatory drug Didox did not provide a further significant recovery (improved 
restoration of only ~4%). However, it is interesting to note that the length of initial segments are 
significantly shorter both 1-week after LPS treatment and 2-weeks after LPS treatment when 
compared to Control. The length of initial segments in Didox treated animals is not significantly 
different from the length of Control animals. Recovery may be spontaneous, but the anti-
inflammatory effects of Didox may serve to accelerate the recovery. Future experiments will 
determine whether Didox treatment can reverse the loss of initial segments noted at earlier time 
points. If Didox does lead to recovery at earlier time points, this would indicate that resolution of 
inflammation can decrease the normal time course for recovery in LPS-induced inflammation.  
 
Microglia become less reactive in Prolonged Inflammation.  
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 Microglia are the resident immune cells of the CNS and are known to respond to 
inflammation in EAE and MS by adopting a reactive, or M1 polarized morphology (Gold et al., 
2006; Heppner et al., 2005; Kipp et al., 2012; Rawji and Yong, 2013; Taetzsch et al., 2015). We 
have previously reported that microglia reactivity closely correlates to EAE progression and is 
resolved following Didox treatment (Clark et al., 2016). A similar tendency is noted in early LPS 
studies. Surprisingly, assessment of microglia morphology indicates that microglia resolve at the 
Chronic EAE time point and 2 week post LPS injection time point in both Didox treated and 
untreated animals. This indicates a resolving inflammatory environment at the end of the EAE 
and LPS-inflammation studies.  
Interestingly, whole cortex lysates reveal increased levels of TNFα at the Chronic EAE 
time point, and these levels were decreased following treatment with Didox. iNOS levels were 
also elevated in Chronic EAE animals and decreased following Didox treatment, but these 
changes were not significant. These results indicate an increased inflammatory environment in 
Chronic EAE, which resolves following treatment with Didox. These findings seem contrary to 
the qualitative assessment of microglia morphology, which indicates a resolved inflammatory 
environment in Didox treated and untreated animals. Our findings support the idea that 
morphological changes alone do not necessarily portray functional aspects of microglia. 
Microglia are versatile cells that exist on a spectrum of activity states rather than a binary 
(inflammatory or surveying) state (Hanisch and Kettenmann, 2007; Taetzsch et al., 2015). 
Further studies will aim to isolate microglia and analyze mRNA expression profiles to determine 
if there are differences between microglia at these time points that is not reflected by 
morphology. The expression of microglia in LPS-induced inflammation will also be assessed to 
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determine whether they are similar to those seen in Chronic EAE studies, and to further elucidate 
a mechanism for the loss and recovery of initial segments.  
 Didox is a broadly acting anti-inflammatory that inhibits cell division through actions as 
a ribonucleotide reductase inhibitor and it also inhibits the inflammation-associated transcription 
factor NFκB (Inayat et al., 2002; Inayat et al., 2010; Matsebatlela et al., 2015; Shah et al., 2015). 
The effects of Didox are broad, and the precise mechanism for reducing prolonged inflammation 
in these studies is not clear. Although microglia are suspected to mediate the loss of initial 
segments, they could also be involved in the recovery seen in LPS-induced inflammation. Didox 
could also be acting peripherally, on cells that infiltrate the CNS during EAE, or on other cells of 
the CNS known to produce inflammatory cytokines. Further experiments are required to 
determine whether Didox acts on microglia to reduce the inflammatory environment in EAE, and 
whether the same mechanism is responsible for LPS-mediated inflammation model. 
Loss of The Axon Initial Segment in Prolonged Inflammation is Reversible.  
 
The studies presented here provide the first evidence that the loss of initial segments in 
prolonged inflammation is reversible. The AIS is known to be a highly plastic structure, with 
altered structure reported in response to electrical activity (Evans et al.; Grubb and Burrone, 
2010; Kuba et al., 2010) as well as in models of traumatic brain injury (Baalman et al., 2015), 
stroke (Hinman et al., 2013; Schafer et al., 2009), and EAE (Clark et al., 2016). Although some 
axonal sprouting was reported in a study of the AIS in white matter stroke (Hinman et al., 2013), 
recovery of the AIS in the weeks following injury has not been reported (Schafer et al., 2009). 
Though results from the Chronic EAE study were underpowered, the loss of initial segments 
observed in LPS-mediated inflammation is reversed in both 2 Week LPS and Didox treated 
animals. These results indicate that loss of the initial segments in prolonged inflammation is 
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reversible. What accounts for the recovery of initial segments in these studies? One possibility is 
that the loss of initial segments is a plastic adaptation in response to inflammation, and the 
underlying AIS cytoskeleton is not lost at the time points investigated. Western blots indicate 
that both major isoforms of βIV spectrin are not decreased in Chronic EAE. The irreversible loss 
of initial segments reported in Schafer et al. (2009) was characterized by the presence of a βIV 
spectrin breakdown product at ~45kD. Differences in βIV spectrin+ bands at ~45kD were not 
observed in the current study, indicating preservation of the cytoskeleton in Chronic EAE. It is 
possible that the presence of the βIV spectrin cytoskeleton is necessary for the recovery noted in 
our study, and loss of the βIV spectrin cytoskeleton observed in Schafer et al. (2009) is an 
indicator of permanent loss of the initial segment. Further experiments will use 
immunocytochemistry and western blotting to determine whether the cytoskeleton is also 
preserved in LPS-mediated inflammation and whether preservation of the AIS cytoskeleton is 
required for recovery of the initial segment after prolonged inflammation.  
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Chapter 6: Automated Quantitation of Initial Segments and NeuN+ 
Cells 
 
 
Automating Image Processing and Quantitation 
 
  An established manual counting method, discussed previously, was used for EAE initial 
segment quantitation (Clark et al., 2016) For the LPS study, I developed a semi-automated 
method for pre-processing images and counting initial segments and nuclei using custom macros 
and Plugins included in the FIJI (FIJI is just ImageJ) distribution of the NIH’s ImageJ software 
(Schneider et al., 2012). A macro is a simple program that runs a series of steps automatically 
(ImageJ). Though simple, macros can be a powerful tool for quickly and accurately analyzing 
large collections of data. Steps of the semi- automated analysis are as follows: Preprocessing, 
quantification, raw data filtering and traditional statistical analysis.  
Preprocessing 	
Raw images are processed into a format easily manipulated in bulk using ImageJ. It is important 
that the original images from the microscope are preserved in the proprietary format in order to 
preserve the metadata for publication and more detailed analysis.  
 
1. Save the images in the proprietary image format of the microscope (i.e. “.czi” or “.lsm” 
for Zeiss® software) to preserve the metadata and the complete image data. Then, create a 
maximum intensity projection saved as a tiff file with identifying information including 
(as applicable): Animal ID, treatment, cohort, slice, and image number.  
2. Move all maximum projections to a folder for batch processing. To split large batches of 
channels, an ImageJ macro called SplitChannelMacro was developed.  
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3. The SplitChannelMacro works by automating the following steps normally taken when 
splitting channels of a multi-channel microscope image. SplitChannelMacro:  
a. Creates new folders for split images called “RedChannel” and 
“GreenChannel”.  
b. Selects an image, runs the ImageJ Split Channel command. 
c. Saves only the relevant channel with a new identifier (“red_” or 
“green_” for our purposes) to the appropriate “RedChannel” or 
“GreenChannel” folder while discarding other channels (the macro 
can be modified to save any or all channels).  
d. Progress can be monitored in the ImageJ log screen and “One 
Channel Conversion is Complete” is printed on the screen upon 
once a loop is completed.  
A version of the SplitChannelMacro used in the analysis of the LPS data is shown in Figure	15.   
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Figure 15. SplitChannelMacro explained. This simple macro automates channel splitting of 
maximum intensity projection “.tiff” files. First, the macro prompts the user to choose a directory 
containing the images and creates new folders for the processed images (A). Then, a loop is 
initiated to process all images in the directory (B). The FIJI split channel command is then 
executed and the relevant images are saved (C). This version saves the “green” and “red” 
channel into the appropriate folders. It can easily be modified to save any or all channels. This 
macro is written for use in ImageJ/FIJI. 
 
 
 
 
 
 
A 
B 
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Quantitation 	
Quantitation of initial segments requires a consistent threshold method for images and the 
Analyze Particles Plugin distributed with FIJI.  A threshold is applied to images, Analyze 
Particles is run, and the output data is filtered and all particles less than 10μm are excluded 
before the final analysis. This length exclusion was set for this study and can be modified to be 
more inclusive. Length is determined using the “Feret’s diameter” option. Feret’s diameter is the 
caliper diameter of the object selected by Analyze Particles. In FIJI, Feret’s diameter refers to the 
maximum caliper diameter of the object (https://imagej.nih.gov/ij/docs/guide/146-30.html) 
(Schneider et al., 2012). Since initial segments are typically linear objects, Feret’s diameter was 
tested and considered an appropriate estimate of length (not shown). Because later data 
processing steps require filtering by length, it is important to set a global scale for the images 
before processing. This can be found under Analyze> Set Scale. The scale is listed in the meta-
data of the original microscope image. Several Plugins are available to threshold images in 
ImageJ (Otsu, Maximum Entropy, Triangle, etc.) ("A Threshold Selection Method" 1979, 
Landini). After comparing several methods for accuracy based on manual counts, we decided to 
use the Otsu threshold method for the LPS study. Otsu threshold comes as a pre-installed option 
in FIJI ("A Threshold Selection Method" 1979, Landini). After a threshold is applied to the 
images, measurements are set in the Analyze Particles Plugin, and a macro is made using the 
Record option in FIJI under the Plugins menu. Plugins>Macro>Record allows simple ImageJ 
macros to be created with no coding required. Simply record the steps that you normally take in 
image processing and save the resulting commands generated in the Record window. For the 
purposes of this study, the Threshold and Analyze Particles selections were recorded.  
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Finding proper settings for the Analyze Particles Plugin is essential to using this method 
for automated analysis. Settings depend on average image quality and require some 
troubleshooting while developing the macro for specific needs. The macro saves overlay for all 
images so any anomalies or questionable results can be manually inspected. Settings were 
evaluated for accuracy by comparing to manual counting of the target particle and by visual 
inspection of output overlay masks. Once the settings are determined for an experiment, they 
should be used consistently for all images in that study. The settings and macro used for 
Ankyrin-G quantification are listed in Figure	16, A, while those used for NeuN are listed in Figure	16, B.  
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Figure 16. Macro and settings for automated quantitation. Settings were optimized for accuracy for initial 
segment and neuronal nuclei quantitation. Once established, settings must be kept consistent throughout analysis. 
Settings and the macro are provided for initial segment quantitation (A), and neuronal nuclei quantitation (B).  
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Once the macro is created, it can be saved as a text file and installed in FIJI for launch on 
startup. Macros can also be used from the raw text form to batch file analysis using the 
Process>Batch>Macro… command in FIJI. The latter method was used for this study as the 
install-ready Plugin is still in development.  
Automated ImageJ steps for quantification: 	
1. Open an image and set the global scale.  
2. Open image for analysis.  
3. Apply threshold to images.   
4. Run the Plugin Analyze Particles (with proper settings).  
5. Filter data. 
6. Save for future analysis.  
The macro automates steps 2-4. The pre-determined settings for image threshold and Analyze 
Particles are built into the macro, and the global scale only needs to be set once per analysis 
session. Sample input, threshold, and output images and measures are shown in Figure	17. 
Manual counts performed for a sample of three saline animals resulted in an average of 85.6± 4.7 
AISs/Field of view (FOV). Automated counts for these same animals resulted in 97.7±11.1 
AISs/FOV (Figure	18). A t-test comparing the values for each mouse revealed no statistical 
difference between the two counting methods. This comparison was repeated with 3 other time 
points and no difference was detected between manual and automated counts (not shown).  
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Figure 17. Procedure for automated image quantitation. First, the Otsu threshold is applied to the image (A,B). Then, 
Analyze Particles is run. Output overlay mask and data are shown (C). Results are then filtered by size using R (D), or 
Microsoft Excel (not shown). 
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Figure 18. No difference is detected between automated counting method and 
manual counting.  A t-test was performed to compare the amount of initial segments 
counted manually to the new automated method of counting. No difference was 
detected between the two methods. This assessment was repeated with three other 
paired groups and no difference was detected between manual and automated 
counting in any group (not shown). 
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Limitations and Conclusions 	
This semi-automated method greatly speeds up image analysis without sacrificing the 
accuracy of manual counting. Analysis can now be performed as soon as images are taken. 
Automation and standard image thresholds also removes user bias, and improves consistency by 
removing inter-user discrepancies-- anyone running the program will get the same results. As 
with any automated process, there are limitations. This process in particular requires images with 
high signal to noise ratios-- antigen retrieval techniques and linear unmixing are recommended. 
There are also inherent limitations when using maximum intensity projections to analyze 3-
dimensional images. Initial segments overlapping in the z-plane may be counted together, 
artificially lowering the true number of initial segments. This is a limitation for both manual and 
automated counting methods, though a qualitative assessment revealed that the degree of overlap 
was minimal in layer V of the cortex. Also, while initial segments touching the four lateral edges 
of the image are excluded by the Analyze Particles Plugin, there is currently not a way to exclude 
initial segments that may pass in or out of the top or bottom edges of the image. This problem 
was noted in Hinman et al. (2013) when the NeuronJ Plugin for FIJI was used to measure initial 
segments. Although this is a concern, the lack of a significant difference between manual 
counting methods which exclude initial segments touching the top or bottom of the stack and this 
automated method leads us to believe that the proportion of AISs passing through the top or 
bottom of the z-plane is similar between groups or negligible (Figure	18).    
The program also picks up a very large number of short particles that are clearly not 
initial segments when manually inspected. This is addressed using the data processing step in 
which the initial segments are filtered by size and anything that is less than 10 μm in length is 
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excluded. After filtering and a comparison to manually processed images, the number of initial 
segments counted with the automated method is not statistically different from the amount 
counted manually (Figure	18). Although we have not yet found a method to completely exclude 
initial segments that pass the filtering step but still pass out of the z-plane, the precision of 
automated counts when compared to the established manual method, and the advantages in speed 
and consistency led us to adopt the method for LPS studies. Future versions of this method will 
attempt to address the limitations. Macros, methods, updates, and future Plugin development will 
be stored and maintained in a Github repository (https://github.com/nkicg6) for download. 
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